Common variation in the vitamin D receptor gene and risk of inflammatory bowel disease in an Irish case-control study

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 9, 2011, Pages 807-812

  Hughes, David J ^a   McManus, Ross ^b   Neary, Paul ^a   O'Morain, Colm ^a   O'Sullivan, Maria ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENTERITIS; FEMALE; GENETIC VARIABILITY; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY;

ADULT; ALLELES; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IRELAND; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL;

EID: 80051720759     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328349283e     Document Type: Article

References (50)

1. Scott E, Gaywood I, Scott B. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut 2000;46:1-8.
2. Kornbluth A, Hayes M, Feldman S, Hunt M, Fried-Boxt E, Lichtiger S, et al. Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria. Am J Gastroenterol 2006;101:1546-1550. (Pubitemid 43980628)
3. EFSA Panel on Dietetic Products NaAN. Scientific Opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. EFSA J 2010;8:1-17.
4. Bendix-Struve M, Bartels LE, Agnholt J, Dige A, Jorgensen SP, Dahlerup JF. Vitamin D3 treatment of Crohn's disease patients increases stimulated T cell IL-6 production and proliferation. Aliment Pharmacol Ther 2010;32:1364-1372.
5. Bartels LE, Jorgensen SP, Agnholt J, Kelsen J, Hvas CL, Dahlerup JF. 1, 25-Dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4 + T cells from patients with Crohn's disease. Int Immunopharmacol 2007;7:1755-1764. (Pubitemid 350046440)
6. Kelly P, Nic Suibhne T, O'Morain C, O'Sullivan M. Vitamin D status and cytokine levels in patients with Crohn's disease. Int J Vitam Nutr Res 2011.; 81: In press.
7. Martinesi M, Treves C, Bonanomi AG, Milla M, Bagnoli S, Zuegel U, et al. Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases. Clin Immunol 2010;136:51-60.
8. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004;80:1717S-1720S.
9. Zhu Y, Mahon B, Froicu M, Cantorna M. Calcium and 1, 25-dihydroxyvitamin D3 target the TNF-a pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005;35:217-224. (Pubitemid 40123868)
10. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003;17:2386-2392. (Pubitemid 37542204)
11. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1, 25- Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000;130:2648-2652.
12. Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, et al. Direct and indirect induction by 1, 25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 2010;285:2227-2231.
13. Jorgensen SP, Agnholt J, Glerup H, Lyhne S, Villadsen GE, Hvas CL, et al. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized doubleblind placebo-controlled study. Aliment Pharmacol Ther 2010;32:377-383.
14. Laverny G, Penna G, Vetrano S, Correale C, Nebuloni M, Danese S, et al. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol Lett 2010;131:49-58.
15. Siffledeen J, Siminoski K, Steinhart H, Greenberg G, Fedorak R. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol 2003;17:473-478. (Pubitemid 37321992)
16. Tajika M, Matsuura A, Nakamura T, Suzuki T, Sawaki A, Kato T, et al. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol 2004;39:527-533. (Pubitemid 38996894)
17. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-1517.
18. Wolters FL, Joling C, Russel MG, Sijbrandij J, De Bruin M, Odes S, et al. Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course. Scand J Gastroenterol 2007;42:333-344.
19. Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases Nat Rev Rheumatol 2010;6:468-476.
20. Vieira V, Hart J, Webster T, Weinberg J, Puett R, Laden F, et al. Association between residences in US northern latitudes and rheumatoid arthritis: a spatial analysis of the Nurses' Health Study. Environ Health Perspect 2010;118:957-961.
21. Jenab M, Bueno-de-Mesquita HB, Ferrari P, Van Duijnhoven FJ, Norat T, Pischon T, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 2010;340:b5500.
22. Thorne J, Campbell MJ. The vitamin D receptor in cancer. Proc Nutr Soc 2008;67:115-127. (Pubitemid 351543394)
23. Uitterlinden AG, Fang Y, Van Meurs JB, Van Leeuwen H, Pols HA. Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. J Steroid Biochem Mol Biol 2004;89-90:187-193. (Pubitemid 38844281)
24. Rukin NJ, Strange RC. What are the frequency, distribution, and functional effects of vitamin D receptor polymorphisms as related to cancer risk? Nutr Rev 2007;65:S96-S101.
25. Motohashi Y, Yamada S, Yanagawa T, Maruyama T, Suzuki R, Niino M, et al. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab 2003;88:3137-3140. (Pubitemid 36877484)
26. Maalej A, Petit-Teixeira E, Michou L, Rebai A, Cornelis F, Ayadi H. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun 2005;6:707-711. (Pubitemid 41741716)
27. McCullough ML, Bostick RM, Mayo TL. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 2009;29:111-132.
28. Kahles H, Morahan G, Todd JA, Badenhoop K. Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes. Genes Immun 2009;10(Suppl 1):S60-63
29. Hugot J-P, Chamaillard M, Zouali H, Lesage S, Cezard J-P, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603. (Pubitemid 32531408)
30. Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011 [Epub ahead of print].
31. Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJ, et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 1998;115:1066-1071. (Pubitemid 28485595)
32. Duerr RH, Barmada MM, Zhang L, Davis S, Preston RA, Chensny LJ, et al. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet 1998;63:95-100. (Pubitemid 30428323)
33. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, Annese V, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009;41:216-220.
34. Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000;47:211-214. (Pubitemid 30489764)
35. Dresner-Pollak R, Ackerman Z, Eliakim R, Karban A, Chowers Y, Fidder HH. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet Test 2004;8:417-420. (Pubitemid 40083108)
36. Naderi N, Farnood A, Habibi M, Derakhshan F, Balaii H, Motahari Z, et al. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 2008;23:1816-1822.
37. McCarthy D, Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F, et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther 2005;21:1073-1083. (Pubitemid 40646532)
38. O'Sullivan M, Nic Suibhne T, Cox G, Healy M, O'Morain C. High prevalence of vitamin D insufficiency in healthy Irish adults. Ir J Med Sci 2008;177:131-134.
39. Lennard-Jones J. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;170:2-6. (Pubitemid 20015811)
40. Nejentsev S, Godfrey L, Snook H, Rance H, Nutland S, Walker NM, et al. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet 2004;13:1633-1639. (Pubitemid 39136719)
41. Gauderman WJ. Sample size requirements for association studies of genegene interaction. Am J Epidemiol 2002;155:478-484. (Pubitemid 34174160)
42. Sweeney C, Curtin K, Murtaugh MA, Caan BJ, Potter JD, Slattery ML. Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 2006;15:744-749.
43. Chen L, Davey Smith G, Evans DM, Cox A, Lawlor DA, Donovan J, et al. Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. Cancer Epidemiol Biomarkers Prev 2009;18:2874-2881.
44. Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, Griffiths LR. Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 1999;83:723-726.
45. Hughes DJ, Hlavata I, Soucek P, Pardini B, Naccarati A, Vodickova L, et al. Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Czech Republic. J Gastrointest Cancer 2010; [Epub ahead of print].
46. Karami S, Brennan P, Rosenberg PS, Navratilova M, Mates D, Zaridze D, et al. Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk. PLoS One 2009;4:e7013.
47. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011;55:96-108.
48. Khanal R, Nemere I. Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr 2007;17:31-47. (Pubitemid 46511617)
49. Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, et al. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18:2540-2548.
50. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010;20:1352-1360.